Who is accountable when an AI system accesses ePHI outside its intended purpose?

Why This Matters for Security Teams

When an AI system touches ePHI outside its intended purpose, the risk is not just technical misuse. It becomes a governance failure, because the covered entity still has to account for access, purpose limitation, and logging even if the workflow was mediated by a tool or model. HIPAA does not create a separate liability bucket for autonomous software. The operational question is therefore not whether the AI “meant” to do harm, but who controlled its access, reviewed its outputs, and constrained its actions.

This is where NHI discipline matters. AI systems often authenticate with secrets, service accounts, or delegated tokens that outlive the task they were meant to support. That pattern is exactly what the Ultimate Guide to NHIs warns against, and it is why identity sprawl becomes an accountability problem, not just an inventory problem. In practice, teams usually discover the real control gap only after a model has already queried more data than the workflow intended, rather than through deliberate purpose-based access review.

For security leaders, the issue is not whether AI can be trusted in general. It is whether the organisation can prove that the AI was constrained to the specific purpose for which ePHI access was approved, as described in the OWASP Non-Human Identity Top 10.

How It Works in Practice

Accountability starts with the service relationship. If an AI workflow is deployed by the covered entity, the entity remains responsible for access design, policy enforcement, monitoring, and incident response. If a business associate operates the system, contract terms can shift some operational obligations, but they do not remove the underlying compliance duty. That means the control question is less about who built the model and more about who approved the data path, who issued the credentials, and who can revoke them.

In practice, the strongest pattern is to treat the AI agent or workload as a non-human identity with narrow, task-scoped access. That means using workload identity, short-lived tokens, and just-in-time authorization rather than static API keys or broad service accounts. Where possible, runtime policy should decide whether the specific request is allowed based on purpose, context, and data sensitivity, not just a preassigned role. This is consistent with emerging guidance in 52 NHI Breaches Analysis, which shows how exposed or over-permissioned identities become the path of least resistance.

• Issue credentials only for the task window, then revoke them automatically.
• Bind access to workload identity and request context, not to a standing role alone.
• Log the request, purpose, dataset touched, and downstream action taken.
• Review whether the model or agent can chain tools into broader access than intended.

For implementation guidance, the OWASP Non-Human Identity Top 10 and current zero trust guidance both support minimizing standing access, while LLMjacking: How Attackers Hijack AI Using Compromised NHIs illustrates how quickly exposed credentials can be abused once an identity is reachable. These controls tend to break down when legacy EHR integrations require long-lived service accounts because the purpose boundary becomes hard to enforce at runtime.

Common Variations and Edge Cases

Tighter purpose-based controls often increase workflow complexity, requiring organisations to balance privacy assurance against integration overhead and operational latency. That tradeoff is especially visible in clinical environments where AI systems support chart summarization, triage, or coding assistance, because those workflows often need temporary access to multiple datasets to function effectively.

Current guidance suggests there is no universal standard for how granular “intended purpose” must be in every AI healthcare deployment. Some organisations define it at the use-case level, while others enforce field-level or encounter-level restrictions. The right answer depends on the sensitivity of the data and the degree of autonomy the system has. If the AI can independently select tools, escalate requests, or reuse tokens across sessions, the organisation should assume the control boundary is weaker than it appears.

Edge cases also arise when a vendor hosts the model but the covered entity controls the data. In that arrangement, accountability can be shared, but the covered entity still needs evidence that the vendor’s access, logging, and deletion practices align with HIPAA obligations. The same is true when an AI assistant is embedded in a broader platform: the organisation cannot rely on product defaults to preserve purpose limitation. That is why the emerging practice is to pair contract controls with technical controls, and to verify both continuously rather than at procurement time.

Related resources from NHI Mgmt Group

• Who is accountable when an AI agent acts outside its intended scope?
• What signals show that an AI agent is operating outside its intended purpose?
• Who is accountable when an AI system moves data outside policy?
• How do you know if third-party support access is operating outside its intended boundary?